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1    Introduction
Major improvements in mammalian cell culture methods 
have been achieved over the last 20 years. Today, high 
titer fed-batch processes have been reported to achieve 
up to 13 g/L, a ten-fold increase since the mid 90s [1, 2]. 
Meanwhile peak cell densities achieved using monoclo-
nal antibody (mAb) producing CHO cell lines have reached 
over 200 × 106 cell/mL [3] with average cell densities used 
in existing fed-batch cell culture processes of approxi-
mately 10 to 20 × 106 cells/mL [4]. 
Primary recovery operations in mammalian cell culture 
processes have typically been designed to provide high 
levels of solids removal collectively aiming to remove sol-
ids >0.1–0.2  µm in diameter. Centrifugation combined 
with depth filtration stages have been described as the 
current workhorses of primary recovery [5–7] in large-scale 
manufacturing, typically achieving 98–99% solids removal 
prior to sterile filtration stages. However as cell culture 
performance has improved dramatically, primary recovery 
and purification operations have been facing increasingly 
challenging feedstreams, and it is unclear whether current 
unit operations can continue to provide feasible process-
ing options in the future. This dilemma provided the impe-
tus for the studies reported in this paper.
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Most mammalian cell culture processes used today 
employ centrifuges fitted with hermetically-sealed feed 
zones, which reduce the levels of shear exposure. How-
ever, energy dissipation levels still reach 0.019 × 106 Wkg-1, 
which in some cases results in significant cell breakage, 
and subsequently impacts depth filter area requirements 
[8]. The key parameter causing variation in solids removal 
performance at a fixed cell density is the cell culture via-
bility at harvest. Generally, efficient solids removal can be 
achieved at viabilities >50% [4]. For cell culture material 
with lower viabilities centrifugation is often considered to 
be more challenging.
At the turn of the century, cell densities by mamma-
lian cell culture required relatively low centrifugal dis-
charge frequencies and the contribution to product loss 
was considered minimal, especially when compared to 
those experienced in microbial processes [9]. 
Subsequent increases in cell densities have resulted 
in the solids loads approaching >10% v/v. Centrifuge effi-
ciency at such high solids contents is generally lower and 
there is a need to desludge the centrifuge more frequent-
ly, potentially leading to a greater degree of product loss 
than previously witnessed.
Depth filtration has been used primarily for solids 
removal of supernatant post centrifugation, and in some 
cases (generally at scales <2000  L) to process material 
direct from cell culture. Most available depth filters use 
charged filtration media and have been demonstrated to 
achieve a level of DNA and host cell protein (HCP) remov-
al [10, 11]. Depth filters tend to be followed by absolute 
pore size rated filters (typically 0.45, 0.2 or 0.1 µm) which 
ensure the removal of solid particulates as well as some 
endotoxins and a degree of viral removal from the cell 
culture harvest material [12]. Together these steps ensure 
a particle-free product solution, which can then proceed 
successfully to packed bed chromatography steps. 
A wide range of alternative technology options for 
primary recovery have been previously identified includ-
ing flocculation [13–17], acid precipitation [18, 19], 
expanded bed absorption [20–22], counter current tan-
gential chromatography [23] and alternating tangential 
flow filtration [24]. Although these operations are expect-
ed to bring benefits in the future, current limitations in 
terms of practical application were reported for example 
potential issues with presence of flocculant in the bulk 
drug substance, low product yields and highly sensitive 
operational performance [6, 16]. Tangential flow microfil-
tration (TFF) options, on the other hand, have been sug-
gested in the past to deliver high processing rates without 
adverse effects on cell viability [25]. This advantage can 
potentially play a key role in reducing cell damage during 
primary recovery of high cell density cell culture feeds, 
subsequently reducing potential impurity releases. Hol-
low fiber membranes have primarily been used in mam-
malian cell perfusion cultures, but are typically not con-
sidered for batch type harvest operations. The membrane 
costs of TFF can be lower than the costs of typical depth 
filtration media, especially where single use modules are 
required, as the TFF membrane media tends to be reus-
able [26].
The pressures to accommodate higher cell density 
feed streams during primary recovery provided the moti-
vation for this paper in which the ability of both current 
and alternative primary recovery technologies to cope 
with predicted future feed profiles were evaluated. Cell 
culture test materials (CCTM) were used for this purpose. 
The method for CCTM generation allowed independent 
control of impurity, product, cell density and viability 
variables to create the perceived most demanding feed 
material conditions [27]. The technologies were evaluated 
based on the following performance criteria: solids remov-
al, yield and impurity removal. The technologies were 
then ranked using a multi-attribute decision-making 
(MADM) technique and the successful candidates were 
assessed further using an economic evaluation and facil-
ity fit criteria.
2    Materials and methods
2.1    Cell culture and cell harvest
Cell culture was carried out using the CY01 cell line, 
kindly donated by Lonza Biologics, in 5 L STRs (B. Braun 
BIOSTAT B-DCU control unit, Sartorius, Epsom, UK) and 
harvested on day 13. Cell culture set points have been 
carried out as previously described in Popova et al. [27]. 
Total cell concentrations at harvest were ~9 × 106 cells/
mL with an average viability of 77%. The harvested mate-
rial was used to generate cell culture test materials with 
the representative most challenging target conditions for 
future primary recovery feeds. These included as a cell 
density of 100 × 106 cell/mL with a cell viability of 40%, 
IgG1 concentration of 20 g/L and a HCP concentration of 
20  g/L. These conditions were selected using a survey 
compiling expert opinion on the likely future cell culture 
profiles to primary recovery. Additionally, a low viability 
was selected to provide a challenging case for the select-
ed technologies. The CCTM generation was described 
previously in detail [27]. The cell culture harvest was con-
centrated and spiked with the volumes of IgG1 and a HCP 
stock to create the required conditions. Apoptosis induced 
cell stock was added to the CCTM in order to achieve the 
target viability of 40%. All cell density and viability meas-
urements were carried out using a ViCellTM (by trypan 
blue exclusion).
2.2    Primary recovery methods
Technologies were selected to represent current and 
alternative primary recovery options. Three centrifuga-
tion (hermetically-sealed disc-stack centrifuge) and pri-
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mary depth filtration options (05SP, 10SP and 30ZA media 
options) were selected to represent the current options, 
where a moderate inlet flowrate to the centrifuge of 
100  L/h was tested. The 05SP depth filtration medium 
typically removed particles of 2–10 µm, the 10SP medium 
removed particles between 1 and 5  µm and the 30ZA 
medium was positively charged and removed particles of 
1–2  µm. Two tangential flow filtration options (0.45  μm 
microfilter Bio-Optimal MF-SLTM and a 0.22  μm anion 
exchange membrane QyuSpeedDTM) were selected to 
represent the alternative options. The CCTM were then 
used as feed to these unit operations.
2.2.1  USD centrifugation
Detailed methodologies for USD centrifugation have been 
described previously [8, 28, 29]. A microwell plate-based 
method described by Tait et al. [30] was used in this 
paper. A rotating shear device was used to mimic the 
shear experienced during the centrifugation step. Hutch-
inson et al. [28] previously correlated the high and low 
energy dissipation rates equivalent to non-hermetic and 
hermetically-sealed disc-stack centrifuge feed zones as 
0.37 × 106 Wkg-1 and 0.019 × 106 Wkg-1. As hermetically-
sealed feed zones are most commonly utilized for mam-
malian cell culture processing at present, only low shear 
centrifugation conditions were mimicked. 
Sheared material was subsequently centrifuged using 
an Eppendorf 5810R bench top centrifuge (Cambridge, 
UK) with an A-4-62 swingout rotor. The fill volumes across 
the plate used were set to give an equivalent feed flow 
rate of 100 L/h in the centrifuge to represent a moderate 
flow rate into a medium scale centrifuge – the CSA-1 
(Westfalia, Oelde, Germany) with a sigma (Σ) value of 
680 m2.
2.2.2  USD depth filtration
Depth filtration media was kindly provided by 3M (Brack-
nell, UK) and was cut in-house to provide a total effective 
area of 0.28 cm2 and inserted into a custom made mani-
fold. Pressure was applied at 100 mbar using a vacuum 
manifold (Tecan VacS, Tecan, UK). Simultaneously a liq-
uid handling arm (Freedom EVO® liquid handling system, 
Tecan, UK) was set up to monitor and record the retentate 
volume throughout the filtration procedure, until the flux 
declined to 80% of the initial value. The scale comparison 
of this method has been discussed previously [31, 32].
The results were analyzed based on the Vmax method-
ology assuming a gradual pore constriction model:
= +




t
V Q V
t
1 1
0 max  
(1)
where V is the total filtrate volume collected over time t, 
Q0 is the initial flow rate, and Vmax is the maximum vol-
ume that can be filtered before the filter is completely 
blocked and the flux reaches zero. 
2.2.3  USD tangential flow filtration
Bio-Optimal MF-SLTM and QyuSpeed DTM (QSD) (Asahi 
Kasei, Japan) hollow fiber modules with areas of 0.0004 m2 
and 0.0006 m2 provided by a single fiber (15 cm height) 
were run at a constant flux of 30 LMH using an AKTA 
Crossflow device (GE Healthcare, Little Chalfont, UK). The 
manifold containing the single hollowfibre was custom 
made and kindly provided by Asahi Kasei. The initial feed 
flow rate was set to achieve a constant shear rate of 
2300 s-1 for both module types, and the backpressure was 
maintained positive by using a manually operated valve 
when required. The module was wetted for 30 min prior 
to the start of the filtration using purified water.
2.3    Analytical techniques
2.3.1 Solids removal performance quantification
The percentage solids removal post filtration operations 
was calculated based on optical density (OD) at 600 nm 
measurements of the feed solution (FOD), OD of the clari-
fied sample (SOD) and normalized to a maximum primary 
recovery performance achieved by passing a clarified 
sample from each technology through a 0.2  µm PES 
syringe filter (S100%).
=
−
−
S
F S
F S
OD OD
OD 100%  
(2)
OD measurements of the feed material were diluted with 
PBS and carried out at cell concentrations of 2 to 
5 × 106 cells/mL within the linear range of the instrument. 
OD measurements of the clarified material were not 
diluted.
Dry solids weight measurements were carried out by 
placing pre-weighed snap-top tubes with 2 mL of sample 
material at 80°C for 48  h, while allowing evaporation. 
Tube weight of the dehydrated material was recorded 
using a scale with a reliability of 0.0001 g (Sartorius Ste-
dim, Epsom, UK). 
2.3.2   Impurity removal and concentration yield 
quantification
DNA and HCP were quantified in stock solutions as well 
as pre and post primary recovery operations. DNA con-
centration was measured using a Quant-iT™ PicoGreen® 
dsDNA Reagent Kit (Invitrogen, Paisley, UK). The BCA 
assay (ThermoFisher Scientific, Loughborough, UK) was 
used for quantifying relative HCP removal. Bovine Serum 
Albumin (ThermoFisher Scientific, Loughborough, UK) 
was used as a standard. HCP concentrations were calcu-
lated by subtracting the quantified IgG1 concentration 
value from the total protein value obtained using the BCA 
assay:
= −HCP TP TYs  (3)
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where TP is the total protein concentration and TYs is the 
total product concentration in the sample. IgG1 concen-
tration was determined using a Protein G column 
(HiTrapTM, GE Healthcare, UK) on an HPLC system (Agi-
lent Technologies, UK), as previously described in Popova 
et al. [27]. Concentration yield (YCP) was calculated for the 
assessment of membrane performance at small scale 
using the following equation:
=Y
TY
TYCP
P
F  
(4)
Where TYP is the product concentration in the post pro-
cessed material and TYF is the product concentration in 
the feed material.
2.3.3  Particle size distribution measurement
Particle size distribution of the clarified material has been 
carried out as previously described in Popova et al. [27].
2.3.4  2D PAGE
Cell culture feed and samples post primary recovery were 
prepared using a 2D Clean-Up Kit (GE Healthcare). 200 µg 
of total protein was loaded onto 7  cm IPGPhor strip 
(pH  3–10 Non-Linear, GE Healthcare, UK). The second 
dimension was run using pre-cast Bis-Tris gels (4–20%, 
7.0 × 7.0 × 0.1 cm ZOOM IPG Well). Staining was carried 
out using SyproRubyTM stain as per manufacturer’s 
instructions. The images were scanned using a Typhoon 
9400 laser scanner (GE Healthcare, UK). SameSpots soft-
ware (TotalLab, Newcastle, UK) was used for image 
analysis. Normalized spot volumes were calculated and 
compared across the gels.
2.4     Performance attribute ranking  
and assessment methodology
A weighted sum multi-attribute decision making (MADM) 
technique [33–36] was used to combine the performance 
data into a single metric. Initially, the calculated technol-
ogy performance values for each attribute were normal-
ized to a 0–1 scale, where the zero value represented the 
worst case performance result and value of one repre-
sented the best case performance result. 
=
−
−
N
P P
P P
A min
max min  
(5)
where PA is the actual figure for a performance attribute 
(e.g. solids removal), Pmin is the minimum value achieved 
by the technologies and Pmax is the maximum value 
achieved by the technologies for the same performance 
attribute. The normalized values were then weighted 
using a ratio of 3 : 2 : 1 for the performance attributes of 
solids removal to DNA removal to HCP removal. This ratio 
was selected based on a survey carried out to quantify 
industry opinion on demands facing primary recovery 
operations in the future (data not included). The subse-
quent sum of the weighted values for each technology 
leads to an overall normalized rank figure (ORN) from 
which technology performances can be compared.
OR Ni i i∑ω=  (6)
=
−
−
OR
OR OR
OR ORN
i min
max min
 (7)
where ωi is the weighted value and the Ni is the normal-
ized value each corresponding to the performance of 
metric i. The resultant ORN also has a value between zero 
and one, therefore representing the least and the most 
efficient option for a given scenario respectively. Selec-
tion criteria of the current typical minimum performance 
in terms of solids removal, yield and impurity removal 
were used as cut off criteria for technology performance.
2.5    Economic evaluation methodology
The economic evaluation was focused on the primary 
recovery stages only using the same worst case input 
conditions as were generated in the practical experi-
ments (Supporting information, Table S1). These were 
combined with the sizing data collected during the 
experimentation and further assumptions (Supporting 
information, Tables S2 and S3) to calculate equipment 
duties required, kg product outputs per batch, capital 
investment and cost of goods (COGPR) outputs for the 
primary recovery operations for three scale scenarios: 
2000 L, 10 000 L and 20 000 L production scales. A detailed 
process economics model was built in Excel (version 
2010) that integrated mass balance, design and cost 
equations so as to generate the key performance metrics 
for the different primary recovery strategies. The mass 
balance and design equations accounted for features 
such as the impact of the cell density on the number of 
centrifugation discharges required (calculated based on 
the centrifuge model used to obtain experimental data) 
and the resulting yield loss. Experimental results were 
used as inputs for worst case filter throughputs and flux 
likely to be achieved. The cost equations were similar to 
those detailed in Farid et al. [37].
2.5.1  Economic evaluation assumptions
Primary recovery operations were defined as those activi-
ties involved in the processing of cell culture material 
during cell culture harvest until the completion of the 
sterile filtration stage prior to chromatographic purifica-
tion. Sizing data including throughput, yield indicator 
and solids removal were collected using the experimental 
set up described in section 2.2. This was combined with 
additional scenario constraints to provide the final sizing 
outputs. The scenario constraints included a target pro-
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cessing time of 6  h. In addition, details on equipment 
performance at the selected scale were constricted to 
specific equipment choices. This included a choice of 
Alpha Laval BTAX215H and Alpha Laval BTAX205 cen-
trifuges, lenticular mobile skids for depth filtration, 8 and 
5 m2 modules for the Bio-Optimal MF SLTM and the QSDTM 
options respectively.
Production was assumed to consist of 17 batches per 
year, with a process length assumed to be 20 days. The 
COGPR comprised of both the direct and indirect costs for 
primary recovery operations only, assuming use of an 
existing facility. The direct costs included materials (e.g. 
filters, single use materials etc.), labor costs (including 
operational labor) and WFI costs. Labor costs were derived 
by assuming a maximum shift length of 8 h as well as a 
requirement of one operator per large scale rig. The indi-
rect costs included depreciation of 10% per annum over 
10 years based on the capital investment. Capital invest-
ment was calculated on reusable equipment (e.g. filtration 
skids, centrifuge units etc.) and auxiliary equipment (e.g. 
pumps) using Lang factors shown in Supporting informa-
tion, Table S4. In order to capture the necessary changes 
involved in the installation of new equipment at a manu-
facutirng site, a Lang factor value of 1 was assigned to 
current technology options. Lang factors capturing the 
costs involved in the installation of alternative equipment 
were estimated to total a value of 3.45.
3    Results and discussion 
3.1     Yield, particle size distribution  
and impurity removal comparison
The performance of three centrifugation and depth filtra-
tion options (05SP, 10SP and 30ZA media) as well as 
two  tangential flow filtration unit options (Bio-Optimal 
MF-SLTM and QSDTM) were investigated when chal-
lenged with the most demanding cell culture material 
conditions (Fig. 1A). A USD set up was used to mimic the 
characteristics of a disk-stack centrifuge operating with 
a hermetically-sealed feed zone and a feed flow rate of 
100 L/h. The centrifuged material was then passed onto 
the USD depth filtration set up using a 0.28 cm2 depth filter 
disc of each of the three media types at a constant pres-
sure of 100 mbar. The resultant filtrate was compared to 
the material which passed through the single fiber set up 
of the Bio-Optimal MF-SLTM module (4  cm2) and the 
QSDTM (6  cm2) at 30 LMH constant flux. Comparisons 
were made in terms of solids removal, concentration yield 
and levels of impurity removal achieved.
Concentration yield across the technology options 
was found to be >80%. The observed product loss may 
have been due to non-specific binding to the cellular and 
debris material as well as the tested membrane surface. 
No significant product loss was seen over time in unpro-
cessed material used as control, at time scales of <5  h 
(data not shown). Initially solids removal was measured 
using OD measurements and subsequent calculation of 
the % solids removal, but this proved unreliable due to the 
high levels of fine particles generated during the USD 
centrifugation step. Therefore solids removal for the USD 
centrifugation step was further analyzed by dry cell 
weight measurement of the supernatant compared to the 
feed and was also normalized using the supernatant 
passed through a 0.22 µm filter. This presented a more 
reliable measure of the centrifugation performance. Solids 
removal was measured for the depth filtration options 
using the OD measurement methodology and was used 
as a rough filter performance indicator. Direct comparison 
between centrifugation and depth filtration solids remov-
al capacities was not made due to the differences in the 
quantification techniques applied.
A typical particle size distribution profile of the CY01 
cell line has been previously shown, where cell debris 
were found in the range of 2–5 μm, cells (including apop-
totic and live) >5 μm [27, 30]. HCP release into the super-
natant stream was also observed, indicating high levels of 
cell damage due to shear. The particle size distribution 
data (Fig. 1B) of the feed material and the supernatant also 
showed an increase in particles between 2–5 µm in diam-
eter, and the presence of some particles between 5–10 µm 
in diameter. An absence of particles with diameters 
above 10 µm in the supernatant stream, was observed. 
The 30ZA option however provided the highest degree of 
solids removal compared to the 5SP and 10SP options, as 
it has the smallest nominal pore size. However, break-
through occurred during filtration and this increased the 
sample pool OD. A ~10% total HCP removal was observed 
when using all three media types, as well as substantial 
DNA removal of 15–20% and 63% using the SP and the ZA 
media respectively. The observed difference in removal 
was expected and can be explained by the positive 
charge provided by the ZA media compared to the SP. 
The Bio-Optimal MF-SLTM and the QSDTM options 
achieved >99% solids removal, however their perfor-
mance differed in terms of impurity removal levels. Oper-
ating with the Bio-Optimal MF-SLTM provided a ~50% 
DNA removal compared to >99% DNA removal using the 
QSDTM and HCP removal of 15 and 20% respectively. The 
Bio-Optimal MF-SLTM media is however uncharged and 
therefore was not expected to result in a high level of DNA 
removal. However high cell mass within the hollow fiber 
may have resulted in entrapment of DNA due to a combi-
nation of physical particle retention and non-specific 
binding to the cellular matter. The QSDTM was expected 
to achieve a high level of DNA removal due to the high 
charge capacity provided by the diethylamine (DEA, 
NH([CH2CH3]2) ligands grafted to the polyethylene (PE) 
membrane material [38].
In terms of particle size distribution, the Bio-Optimal 
MF-SLTM showed the lowest presence of solids across the 
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particle size range. The QSD, Bio-Optimal as well as the 
centrifugation and 30ZA options showed an overall low 
solids content, with the solids fraction remaining below 
3%. 
3.2    HCP removal profile comparison
One of the key functions of the unit operations following 
the solids removal/clarification stages is HCP removal. 
Protein A typically removes ~95–99% of HCPs [39]. How-
ever, HCP reduction prior to protein A may have benefits 
in terms of protein A resin lifetime. In addition, specific 
HCP removal may still be a concern for some processes or 
cases where upstream batch-to-batch variability may 
cause expression of HCPs which are particularly difficult 
to remove. Therefore, the HCP removal potential of each 
technology option was investigated further in order to 
gain an understanding of the types of HCPs these tech-
nologies tend to remove. 2D PAGE gels of the starting 
material and post primary recovery operations were run in 
triplicate. HCP normalized spot volumes were compared 
to the CCTM gels in four gel areas numbered Q1-Q4 
(Fig. 2A), representing different pI and molecular weight 
combinations (low pI and low molecular weight; high pI 
and low molecular weight; low pI and high molecular 
weight; high pI and high molecular weight). Spot increas-
es and decreases were calculated relative to the CCTM 
gels and included any new spots which were not origi-
nally found on the CCTM gel images (Fig.  2B). This 
method was used to indicate any specific areas of HCP 
removal which a particular technology can provide. High-
est spot number decreases were seen in the low molecular 
weight and high pI region across all the technologies (Q4). 
This may be due to some association of these HCP posi-
tively charged HCPs to the cell debris accumulating on the 
retentate size of the tested membranes. Centrifugation 
plus 30ZA, Bio-Optimal MF SLTM and QSDTM options also 
showed higher HCP removal in the Q3 region. Highest 
spot increases were observed in the Q1 region for all the 
technologies except the centrifugation plus 30ZA option. 
The centrifugation and 30ZA option showed higher net 
spot decreases than increases across all the quadrants.
A dark line of unresolved lower pI HCPs can be seen 
on the feed material gel (Fig. 2A). Due to the poor resolu-
tion these were not quantified, but a significant reduction 
of this region was observed post QSDTM application and 
some reduction was observed post Bio-Optimal MF-SLTM 
application (images not shown).
3.3    Performance attribute ranking and assessment
An MADM additive weighting technique was used to 
assess the practical findings and quantify the overall per-
formance by considering the performance attributes tak-
en together. A potential scenario for the selection criteria 
was then explored, where yield and purity targets were 
selected based on the current platform processes as well 
as literature data. 
Solids removal, DNA reduction and HCP reduction 
results were normalized based on the minimum and 
maximum values for each attribute to obtain a rating 
value between zero and one (Supporting information, 
Table S1). The example values for a current platform are 
also shown. The ratings were then obtained for each tech-
nology and each of the selected performance attributes. 
An overall purity weighted score was then obtained and 
compared across the technologies (Supporting informa-
tion, Table S5). These results reflected the practical data, 
Figure 1.  (A) Primary recovery technology performance under the worst case screening study conditions generated using the CCTM in terms of % concen-
tration yield, % DNA removal performance, % solids removal and % HCP removal. Vertical error bars show the standard deviation of technical replicates 
(n = 3). (B) Particle size distributions of samples post solids removal using the different primary recovery technology options (B i) supernatant fraction 
post USD centrifugation, (B ii) permeate fraction post centrifugation followed by depth filtration using 05SP media, (B iii) permeate fraction post centrifu-
gation followed by depth filtration using 10SP media, (B iv) permeate fraction post centrifugation followed by depth filtration using 30ZA media, (B v) per-
meate fraction post tangential flow filtration using Bio-Optimal MF-SLTM, (B vi) permeate fraction using QSDTM in tangential flow filtration mode. The aver-
age distributions are plotted from n = 5 technical replicates.
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where the QSDTM displayed the highest score, followed by 
Bio-Optimal MF-SLTM, the centrifugation plus 30ZA, cen-
trifugation plus 10SP and finally centrifugation plus 05SP 
option. Based on the normalized weighted score of the 
“current operational level” selected, centrifugation plus 
05SP as well as centrifugation plus 10SP options were 
seen to fall below the desired level, while centrifugation 
plus 30ZA, Bio-Optimal MF-SLTM and the QSDTM options 
performed above the set base line. Additional minimum 
yield criteria were then also implemented and set to be 
90% (Fig. 3A). As a result the Bio-Optimal and the QSDTM 
technologies met both of the set criteria while the cen-
trifugation plus 30ZA option met the target purity criteria 
but not the yield criteria. The centrifugation plus 10SP 
Figure 2.  2D PAGE gel analysis of CCTM feed and samples post primary recovery using each of the selected technologies. The gels were divided into four 
quadrants based on gel coordinates. (A) 2D PAGE gel of the CCTM feed divided into four quadrants – (Q1) low pI and low molecular weight region, (Q2) 
high pI and low molecular weight region, (Q3) low pI and high molecular weight region, (Q4) high pI and high molecular weight region. (B) Increases and 
decreases in the normalized spot volumes compared to the CCTM feed in each quadrant using SameSpots software. Results were calculated using the 
average of three technical replicates for each of the tested conditions.
Figure 3.  (A) Primary recovery technology performance scores calculated using an MADM additive weighting technique. The normalized weighted score 
was calculated for purity by assuming a 3 : 2 : 1 weighting ratio of solids removal : DNA removal : HCP removal. These scores are presented for centrifuga-
tion plus 05SP depth filtration media option, centrifugation plus 10SP depth filtration media option, centrifugation plus 30ZA depth filtration media option 
Bio-Optimal-MF-SLTM option, and the QSDTM option. The scores were plotted against the yield result obtained in terms of product concentration. Technol-
ogy performance targets were applied based on existing processes to obtain a yield target and a purity target for technology selection. (B) Sensitivity analy-
sis on score weighting performed by altering the DNA : HCP weighting ratio. Normalized weighted score for the selection criteria rating based on current 
operational performance.
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option met the yield criteria but not the purity criteria and 
the centrifugation plus 05SP option met neither of the 
criteria. If reducing the acceptable yield criteria to 80% is 
possible, the centrifugation plus 30ZA option would not 
be ruled out. Accounting for this possibility we did not 
rule out the centrifugation plus 30ZA option at this stage.
A sensitivity analysis was performed on the weighting 
ratio of DNA : HCP removal to determine the impact on 
the ranking of the technologies. Fig. 3B illustrates that if 
the HCP removal score is considered more important than 
DNA removal (DNA : HCP removal weighting ratio <0.75), 
the normalized weighted score of the centrifugation plus 
30ZA option falls below the acceptable threshold values. 
The ranking of centrifugation plus 05SP and centrifuga-
tion plus 10SP options also switches at a DNA  :  HCP 
removal ratio below 0.25 where centrifugation plus 10SP 
option scores fall below the 05SP alternative. These trends 
are driven by the very small differences in HCP removal 
performances of the technologies and the much greater 
differences in DNA removal performances.
3.4    Cost of goods comparison
In order to compare the economic impact of the primary 
recovery technology selection, the cost of goods was cal-
culated for the primary recovery operations defined as all 
activities post cell culture harvest, not including protein 
A purification operation and beyond.
Throughput data for the three depth filtration options 
and the Bio-Optimal MF-SLTM and the QSDTM was used 
in the comparison. The Bio-Optimal MF-SLTM was found 
to provide the highest capacity of >110  L/m2, followed 
by the 05SP, 10SP QSDTM and 30ZA media (101, 88, 82, 
32 L/m2 respectively). This is consistent with a previously 
reported throughput range seen in the SP filtration media 
when processing high cell density material [40]. 
This data together with the unit operation assump-
tions and the performance data presented in the previous 
section provided the inputs to the cost of goods model 
(Supporting information, Table S2). Based on the technol-
ogy performance results, economic outcomes are pre-
sented for those technology options which fulfilled one or 
more performance target criteria (i.e. centrifugation plus 
30ZA; Bio-Optimal MF-SLTM; QSDTM). The centrifugation 
plus 30ZA media option achieved the lowest kg/batch 
output of product, when compared to both of the TFF 
options (Fig. 4A). This low output was due to the yield 
losses expected during the large scale centrifugation 
operation. At such high solids concentrations, the num-
ber of discharge operations required by the selected cen-
trifuge models, reduced the overall step yield from ~90% 
to 30–40% at the three scale scenarios. This had a consid-
erable impact on the cost of goods (RMU/g) output 
(Fig. 4B), across the scales where the centrifugation plus 
30ZA option is the most costly followed by the QSDTM and 
the Bio-Optimal MF-SLTM. The RMU/g figures were 
benchmarked against a commercially available software 
(BioSolve, BioPharm Services, Bucks, UK), which yielded 
results within the same order of magnitude. 
Figure 4. Kilogram per batch output (A), COGPR/g (B) and floor space 
required (C) for the primary recovery technology options at three scale 
scenarios of 2000 L, 10 000 L and 20 000 L. Analysis based on experimen-
tal performance at the selected worst case feed to primary recovery condi-
tions, assuming 17 batches per year production at each scale. Cost of 
goods (COGPR/g) account for primary recovery costs only. Floor space 
considerations assumed a minimum of 1 m operational space around 
each unit. Results are presented for the centrifugation plus 30ZA option 
Bio-Optimal MF-SLTM option ; QSDTM option, centrifugation plus 30ZA 
(primary clarification only) Bio-Optimal MF-SLTM QSDTM; In (C), the num-
bers above the bars indicate the number of filtration skids required in each 
given scenario. An example of an existing current worst case primary 
recovery space requirement for a 20 000 L process is indicated for primary 
clarification (– – –) and primary and secondary clarification collectively 
(········).
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The space required to facilitate the use of the equip-
ment required was also investigated (Fig. 4C). The cen-
trifugation plus 30ZA media was found to require >200 m2 
of floor space to accommodate the skids at the 20 000 L 
scale, which totalled 23 units. A current 20 000 L facility 
was used as a benchmark to provide facility fit con-
straints. It can accommodate 10 skids for primary clarifi-
cation filters and 10 skids for secondary clarification filters 
(as the current worst case scenario). The space required 
to accommodate the 30ZA primary clarification skids at 
the 20 000 L scale at the set scenario conditions was more 
than double this. Although the number of skids required 
to accommodate the QSDTM option was also high, second-
ary filtration prior to the sterile filters is not required, and 
would fit into this hypothetical facility. The Bio-Optimal 
MF-SLTM option required approximately a quarter of this 
floor space. This indicates that in cases where existing 
facilities are used for new processes or alternative unit 
operations, the TFF options may prove to be more easily 
accommodated.
Material costs dominate the COGPR/batch in all tech-
nology cases across the scales (Fig. 5A). The sizing of the 
Figure 5.  (A) Comparison of COGPR breakdown at each scale scenario on a category basis for indirect costs , material costs and labor costs, for the prima-
ry recovery operations only. (B) Material and WFI costs breakdown at the10 000 L scale scenario.
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depth filtration and TFF modules in each scenario were 
ensured to fit processing time criteria of process comple-
tion within 6 h, allowing for 2 h for CIP of the centrifuge 
and the TFF rigs. For the purpose of these calculations it 
was assumed that one operator will be required for each 
rig in the processing facility. The increased labor costs in 
the case of centrifugation plus 30ZA reflect the depth fil-
tration rig requirement in comparison to the Bio-Optimal 
MF-SLTM and QSDTM options.
The QSDTM option had the highest cost per batch, 
which is approximately double the cost of the centrifuga-
tion plus 30ZA option and over three times the cost of 
Bio-Optimal MF-SLTM. This is due to the high cost per 
module, as the technology is designed and priced to com-
pete with anion exchange resins and membranes (Sup-
porting information, Table S3). The QSDTM module cost 
comprises 80% of the total COGPR/batch compared to the 
60–70% in the centrifugation plus 30ZA and Bio-Optimal 
MF-SLTM cases (Fig. 5B). In addition, WFI costs make up 
10–20% of the batch cost in the case of the TFF options 
compared to 2% in the case of centrifugation plus 30ZA. 
The lowest cost operation across the scale scenarios 
is the Bio-Optimal MF-SLTM, due to the high throughput 
it achieves and the relatively low cost of the modules 
compared to the QSDTM. The base case reusability 
assumed for both TFF options was 10 times. However 
increasing membrane reusability beyond 50 times sig-
nificantly reduces the RMU/g output. However, options 
including centrifugation can benefit from economies of 
scale once a larger centrifuge model is required (scales 
>5000 L). 
4    Concluding remarks
Using a combination of cell culture test materials (CCTM), 
ultra scale-down technologies, multi-attribute decision-
making methods, process economics and facility fit con-
siderations, this paper has demonstrated a methodology 
and results for achieving a screening of current and alter-
native primary recovery technologies. The example tech-
nologies tested included three centrifugation and depth 
filtration options (using 05SP, 10SP and 30ZA media), and 
two alternative tangential flow filtration options (using 
Bio-Optimal MF-SLTM and QSDTM hollow fiber modules). 
Similar HCP removal levels were reached across all the 
tested technologies, however removal of specific HCP 
groups varied. Up to 99% DNA removal was achieved 
using the QSDTM, with lower levels of DNA removal using 
the other options.
MADM analysis as well as selection based on current 
technology performance criteria showed that only two 
options met the yield and purity criteria: Bio-Optimal MF-
SLTM and the QSDTM. The centrifugation plus the 30ZA 
option met the purity criteria but not the yield criteria. 
The options were further evaluated based on their eco-
nomic performance. This showed the centrifugation plus 
30ZA option to be the least cost-effective across the 
2000 L, 10 000 L and 20 000 L scale scenarios and not fit 
the facility constraints set based on a typical existing 
large-scale facility. The Bio-Optimal MF-SLTM option was 
the most cost-effective option across the 2000–20 000 L 
scales of operation. 
Economic and MADM analysis of the alternative tech-
nologies has been used to identify primary recovery 
options for the future. The QSDTM was found to provide 
greater capability for DNA removal prior to purification 
operations, however remained a costly alternative. The 
Bio-Optimal MF-SLTM offered a similar level of solids 
removal but was more cost-effective. Specific process 
requirements as well as other technology alternatives 
have each to be taken into account to further select a cost-
effective and appropriate technology choice. 
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